16.21
-0.25(-1.52%)
Currency In USD
| Previous Close | 16.46 |
| Open | 16.58 |
| Day High | 16.69 |
| Day Low | 16.2 |
| 52-Week High | 29.12 |
| 52-Week Low | 15.83 |
| Volume | 63,358 |
| Average Volume | 97,735 |
| Market Cap | 237.41M |
| PE | -2.44 |
| EPS | -6.64 |
| Moving Average 50 Days | 18.23 |
| Moving Average 200 Days | 23.91 |
| Change | -0.25 |
If you invested $1000 in Anika Therapeutics, Inc. (ANIK) 10 years ago, it would be worth $411.63 as of January 03, 2025 at a share price of $16.21. Whereas If you bought $1000 worth of Anika Therapeutics, Inc. (ANIK) shares 5 years ago, it would be worth $313.66 as of January 03, 2025 at a share price of $16.21.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 23, 2024 9:01 PM GMT
BEDFORD, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and CEO of Anika, will present at
Anika To Participate in December 2024 Investor Conferences
GlobeNewswire Inc.
Nov 22, 2024 9:16 PM GMT
BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that senior management will participate in the following upcoming conf
Anika Reports Third Quarter 2024 Financial Results
GlobeNewswire Inc.
Oct 31, 2024 11:05 AM GMT
Updating 2024 fiscal year guidance to reflect announced changes to business strategy, including the sale of Arthrosurface and planned divestiture of Parcus Medical, and U.S. OA Pain Management headwinds Strategy to focus on market leading OA Pain Man